|
| |
| | | 58351 | | 19.11.2008 | | Janssen-Cilag AG | | | | | | | 01.08.2023 | | | | | | 01.01.30. | | 05.09.2023 | | 01.01.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Jurnista 8 mg | Retardtabletten | Retard-Tabletten (Hydromorphon Hydrochlorid 8 mg) | N02AA03 | PI | | 02 | Jurnista 16 mg | Retardtabletten | Retard-Tabletten (Hydromorphon Hydrochlorid 16 mg) | N02AA03 | PI | | 03 | Jurnista 32 mg | Retardtabletten | Retard-Tabletten (Hydromorphon Hydrochlorid 32 mg) | N02AA03 | PI | | 05 | Jurnista 4 mg | Retardtabletten | Retard-Tabletten (Hydromorphon Hydrochlorid 4 mg) | N02AA03 | PI |
|
|
|
